Core Laboratories CLB Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Core Laboratories's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Core Laboratories's noncontrolling interests in subsidiaries?
- Core Laboratories (CLB) reported noncontrolling interests in subsidiaries of $6.26M in Q1 2026.
- How has Core Laboratories's noncontrolling interests in subsidiaries changed year-over-year?
- Core Laboratories's noncontrolling interests in subsidiaries increased by 4.9% year-over-year, from $5.97M to $6.26M.
- What is the long-term trend for Core Laboratories's noncontrolling interests in subsidiaries?
- Over 3 years (2022 to 2025), Core Laboratories's noncontrolling interests in subsidiaries has grown at a 9.8% compound annual growth rate (CAGR), from $4.7M to $6.22M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.